Your browser doesn't support javascript.
loading
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study.
Sant, Milena; Meneghini, Elisabetta; Bastos, Joana; Rossi, Paolo Giorgi; Guevara, Marcela; Innos, Kaire; Katalinic, Alexander; Majuelo, Leire Gil; Marcos-Gragera, Rafael; Molinié, Florence; Rapiti, Elisabetta; Vizcaino, Ana; Zadnik, Vesna; Minicozzi, Pamela.
Afiliação
  • Sant M; Analytical Epidemiology and Health Impact Unit, Research Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy. milena.sant@istitutotumori.mi.it.
  • Meneghini E; Analytical Epidemiology and Health Impact Unit, Research Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
  • Bastos J; Portuguese Institute of Oncology Francisco Gentil (IPO Coimbra), Coimbra, Portugal.
  • Rossi PG; Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Guevara M; Navarra Public Health Institute, Pamplona, Spain.
  • Innos K; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Katalinic A; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Majuelo LG; Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia.
  • Marcos-Gragera R; Institut für Sozialmedizin und Epidemiologie, Institut für Krebsepidemiologie e.V, Universität Lübeck, Lübeck, Germany.
  • Molinié F; Public Health Division of Gipuzkoa, Biodonostia Health Research Institute, Ministry of Health of the Basque Government, San Sebastian, Spain.
  • Rapiti E; CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
  • Vizcaino A; Epidemiology Unit and Girona Cancer Registry, Department of Health, Catalan Institute of Oncology (ICO), Girona, Spain.
  • Zadnik V; Loire-Atlantique/Vendée Cancer Registry, Nantes, France.
  • Minicozzi P; SIRIC ILIAD INCa-DGOSInserm_12558, CHU Nantes, Nantes, France.
Breast Cancer Res Treat ; 183(2): 439-450, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32651753

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Bases de Dados Factuais / Fatores Etários / Antineoplásicos Hormonais / Receptor alfa de Estrogênio / Recidiva Local de Neoplasia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Bases de Dados Factuais / Fatores Etários / Antineoplásicos Hormonais / Receptor alfa de Estrogênio / Recidiva Local de Neoplasia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália